Acerus Pharmaceuticals Corporation Aktie Toronto S.E.
Aktien
A3DHGW
CA00444G4051
ASP
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01.05.18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17.07.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09.09.13 |
Borys Chabursky
BRD | Director/Board Member | - | 20.12.15 |
% 1. Jan. | Kap. | |
---|---|---|
+33.25% | 704 Mrd. | |
+28.59% | 577 Mrd. | |
-3.55% | 348 Mrd. | |
+18.16% | 327 Mrd. | |
+4.36% | 288 Mrd. | |
+14.81% | 234 Mrd. | |
+4.93% | 198 Mrd. | |
-9.78% | 194 Mrd. | |
-3.69% | 147 Mrd. |